- Ramirez-Sanchez, Claudia;
- Kozuch, Jade;
- Shah, Mita M;
- Berumen, Jennifer;
- Mekeel, Kristin;
- Schnickel, Gabriel;
- Taremi, Mahnaz;
- Golts, Eugene;
- Afshar, Kamyar;
- Adler, Eric;
- Pretorius, Victor;
- Aslam, Saima
A 7-day course of glecaprevir/pibrentasvir started in the preoperative period prevented transmission of hepatitis C virus (HCV) from viremic donors to 10 HCV-negative recipients (2 heart, 1 lung, 6 kidney, 1 heart/kidney) with 100% sustained virological response at 12 weeks.